[1]
2026. IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL OUTCOMES AND ADVERSE EVENTS. Frontier in Medical and Health Research. 4, 5 (May 2026), 871–886.